BRIEF CHEMOIMMUNOTHERAPY RITUXIMAB (R)-FND /- R MAINTENANCE IS EFFECTIVE AND SAFE IN NEWLY DIAGNOSED FOLLICULAR LYMPHOMA ELDERLY PATIENTS: AN INTERGRUPPO ITALIANO LINFOMI (IIL) RANDOMIZED TRIAL

U. VITOLO;M. LADETTO;C. BOCCOMINI;E. GAMBA;I. ALVAREZ;L. BALDINI;A. CHIAPPELLA;P. CORRADINI;A. DE RENZO;DI RAIMONDO, FRANCESCO;A. EVANGELISTA;A. GALLAMINI;A. GUARINI;B. MANTOAN;M. MARTELLI;L. ORSUCCI;G. PARVIS;M. PETRINI;A. PINTO;S. POZZI;A. PULSONI;L. RIGACCI;E. RUSSO;C. TARELLA;A. TUCCI;F. ZAJA;E. GALLO;BRIEF CHEMOIMMUNOTHERAPY RITUXIMAB R. FND R. MAINTENANCE IS EFFECTIVE AND SAFE IN NEWLY DIAGNOSED FOLLICULAR LYMPHOMA ELDERLY PATIENTS AN INTERGRUPPO ITALIANO LINFOMI IIL RANDOMIZED TRIAL

2009-01-01